Treg-cell therapy - t-cell Europe
Latest Information Update: 05 Sep 2023
At a glance
- Originator t-cell Europe
- Class T lymphocyte cell therapies
- Mechanism of Action Immunomodulators; T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Renal transplant rejection
Most Recent Events
- 05 Sep 2023 Discontinued - Preclinical for Renal transplant rejection (Prevention) in Germany (Parenteral)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Renal-transplant-rejection(Prevention) in Germany (Parenteral)
- 12 Jul 2016 Preclinical development is ongoing in Germany